SFS
ABUS icon

Sowell Financial Services’s Arbutus Biopharma ABUS Stock Holding History

Sowell Financial Services’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,475
Closed -$4K – 530
2021
Q1 		$4K Buy
1,475
+550
+59% +$2.12K ﹤0.01% 2643
2020
Q4 		$3K Buy
+925
New +$3.24K ﹤0.01% 2377

Other funds holding ABUS

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Sowell Financial Services's ABUS Position: Q2 2021 in Review

Sowell Financial Services sold out of Arbutus Biopharma (ABUS) in Q2 2021, closing a stake of 1,475 shares — an estimated $4K sold.

Sowell Financial Services first reported a position in ABUS in Q4 2020 and held it in 2 quarters. The position peaked at $4K in Q1 2021. 91 funds tracked by Wall St. Rank hold ABUS as of Q2 2021.

  • Sowell Financial Services reported no remaining Arbutus Biopharma position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,475 Arbutus Biopharma shares in Q2 2021, an estimated $4K.
  • Sowell Financial Services first reported a position in Arbutus Biopharma in Q4 2020 and held it in 2 quarters.
  • Sowell Financial Services's Arbutus Biopharma position peaked at $4K in Q1 2021.
  • 91 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.